Drugs / Papverine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02362139 | Feb 2015 → Feb 2017 | — | eran ashwal | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Papverine | “80 mg of Intra-muscular (IM) Papverine during the latent phase of labor” NCT02362139 ↗ |
| Route | Intramuscular | “Intra-muscular (IM) Papverine” NCT02362139 ↗ |